liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Photobleaching behavior of protoporphyrin IX during 5-aminolevulinic acid marked glioblastoma detection
Linköping University, Department of Biomedical Engineering, Biomedical Instrumentation. Linköping University, The Institute of Technology. (MINT)ORCID iD: 0000-0002-0555-8877
Linköping University, Department of Biomedical Engineering, Biomedical Instrumentation. Linköping University, The Institute of Technology. Östergötlands Läns Landsting, Reconstruction Centre, Department of Neurosurgery. (MINT)
Dept. of Physics, Lund University, Lund, Sweden.
Linköping University, Department of Biomedical Engineering, Biomedical Instrumentation. Linköping University, The Institute of Technology. (MINT)ORCID iD: 0000-0002-0012-7867
2009 (English)In: Photonic Therapeutics and Diagnostics V / [ed] Nikiforos Kollias; Bernard Choi; Haishan Zeng; Reza S. Malek; Brian J. Wong; Justus F. R. Ilgner; Kenton W. Gregory; Guillermo J. Tearney; Laura Marcu; Henry Hirschberg; Steen J. Madsen, SPIE - International Society for Optical Engineering, 2009, 716131-1-716131-8 p.Conference paper, Published paper (Other academic)
Abstract [en]

The highly malignant brain tumor, glioblastoma multiforme (GBM), is difficult to fully delineate during surgical resection due to its infiltrative ingrowth and morphological similarities to surrounding functioning brain tissue. Selectiveness of GBM to 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PpIX) is reported by other researchers to visualize tumor margins under blue light microscopy. To allow objective detection of GBM, a compact and portable fiber optic based fluorescence spectroscopy system is developed. This system is able to deliver excitation laser light (405 nm) in both the continuous and pulsed mode. PpIX fluorescence peaks are detected at 635 and 704 nm, using a fiber-coupled spectrometer. It is necessary to optimize the detection efficiency of the system as the PpIX quickly photobleaches during the laser illumination. A light dose of 2.5 mJ (fluence rate = 9 mJ/mm2) is experimentally approved to excite an acceptable level of fluourescence signal arising from glioblastoma. In pulsed illumination mode, an excitation dose of 2.5 mJ, with a dark interval of 0.5 s (duty cycle 50%) shows a significantly shorter photobleaching time in comparison to the continuous illumination mode with the same laser power (p < 0.05). To avoid photobleaching (the remaining signal is more than 90% of its initial value) when measuring with 2.5 mJ delivered energy, the time for continuous and pulsed illumination should be restricted to 2.5 and 1.1 s, respectively.

Place, publisher, year, edition, pages
SPIE - International Society for Optical Engineering, 2009. 716131-1-716131-8 p.
Series
Proceedings of SPIE (Progress in biomedical optics and imaging), ISSN 1605-7422 ; 7161
Keyword [en]
Photobleaching, glioblastoma multiforme, 5-aminolevulinic acid induced protoporphyrin IX
National Category
Biomedical Laboratory Science/Technology
Identifiers
URN: urn:nbn:se:liu:diva-19938DOI: 10.1117/12.808156ISI: 000285713200060ISBN: 9780819474070 (print)OAI: oai:DiVA.org:liu-19938DiVA: diva2:231849
Conference
Photonic Therapeutics and Diagnostics V, 24 January 2009, San Jose, CA, USA
Note

Copyright 2009 Society of Photo-Optical Instrumentation Engineers. One print or electronic copy may be made for personal use only. Systematic reproduction and distribution, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper are prohibited. The original publication is: Neda Haj-Hosseini, Johan Richtera, Stefan Andersson-Engels and Karin Wårdell, Photobleaching behavior of protoporphyrin IX during 5-aminolevulinic acid marked glioblastoma detection, 2009, Proceedings of SPIE, (7161), 716131. http://dx.doi.org/10.1117/12.808156

Available from: 2009-08-18 Created: 2009-08-17 Last updated: 2017-02-10Bibliographically approved

Open Access in DiVA

fulltext(378 kB)1022 downloads
File information
File name FULLTEXT01.pdfFile size 378 kBChecksum SHA-512
76464fe99bd3005ba7b230a5abf44c5e6db83844e9de765bc1e9ea10d4a03a93b97a1d6b5a2dcb01c5505a0179386d50daecdcf9bd18b2dfbfbc95954739f309
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Haj-Hosseini, NedaRichter, JohanWårdell, Karin

Search in DiVA

By author/editor
Haj-Hosseini, NedaRichter, JohanWårdell, Karin
By organisation
Biomedical InstrumentationThe Institute of TechnologyDepartment of Neurosurgery
Biomedical Laboratory Science/Technology

Search outside of DiVA

GoogleGoogle Scholar
Total: 1022 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
isbn
urn-nbn

Altmetric score

doi
isbn
urn-nbn
Total: 702 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf